# ![@BioVie_Pharma Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1673894970518904840.png) @BioVie_Pharma BioVie Inc

BioVie Inc posts on X about $bivi, ceo, resistance, community the most. They currently have [---] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours.

### Engagements: [--] [#](/creator/twitter::1673894970518904840/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1673894970518904840/c:line/m:interactions.svg)

- [--] Month [---] +23%
- [--] Months [---] -16%
- [--] Year [-----] +534%

### Mentions: [--] [#](/creator/twitter::1673894970518904840/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1673894970518904840/c:line/m:posts_active.svg)


### Followers: [---] [#](/creator/twitter::1673894970518904840/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1673894970518904840/c:line/m:followers.svg)

- [--] Month [---] +1%
- [--] Months [---] +13%
- [--] Year [---] +2.40%

### CreatorRank: undefined [#](/creator/twitter::1673894970518904840/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1673894970518904840/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  [cryptocurrencies](/list/cryptocurrencies)  [stocks](/list/stocks) 

**Social topic influence**
[$bivi](/topic/$bivi), [ceo](/topic/ceo), [resistance](/topic/resistance), [community](/topic/community), [in the](/topic/in-the), [virtual](/topic/virtual), [science](/topic/science), [$biviw](/topic/$biviw), [decentralized](/topic/decentralized), [winner of](/topic/winner-of)

**Top accounts mentioned or mentioned by**
[@bioviepharma](/creator/undefined) [@feisv](/creator/undefined) [@proactivex](/creator/undefined) [@cpiller](/creator/undefined) [@newtothestreet](/creator/undefined) [@practicalneuros](/creator/undefined) [@neurologylive](/creator/undefined) [@keystonesymp](/creator/undefined) [@academicmededu](/creator/undefined) [@plzsolvecfs](/creator/undefined) [@patientled](/creator/undefined) [@vincemedia1](/creator/undefined) [@michaeljfoxorg](/creator/undefined) [@davisphinneyfnd](/creator/undefined) [@parkinsondotorg](/creator/undefined) [@natimmunol](/creator/undefined) [@proactive_x](/creator/undefined) [@redchip](/creator/undefined)

**Top assets mentioned**
[Mastercard, Inc. (MA)](/topic/$ma)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Were grateful for the collaboration and insights from the global community at #mds2023 . Together were stronger in the fight against Parkinsons Disease"  
[X Link](https://x.com/anyuser/status/1696967187011944955)  2023-08-30T19:24Z [--] followers, [--] engagements


"Memory is the thread that weaves the tapestry of our lives. Let's unite in the fight against Alzheimer's spreading awareness and support. Together we can light the way toward a brighter future where memories are cherished and never forgotten. 💪 💜🧠 #Alzheimers"  
[X Link](https://x.com/BioVie_Pharma/status/1699398611077898280)  2023-09-06T12:26Z [---] followers, [--] engagements


"Onsite at #CTAD23 Join us at 12:20pm ET in the Grand Ballroom AB - Floor [--] (Mezzanine Level) for the oral presentation of blinded data from our recently completed Phase [--] clinical trial in mild to moderate #AlzheimersDisease. #AlzheimersResearch #Dementia $BIVI"  
[X Link](https://x.com/BioVie_Pharma/status/1717165980940415038)  2023-10-25T13:07Z [--] followers, [----] engagements


"Our blinded data presented at #CTAD23 suggest that NE3107 is biologically active and may have an impact across endpoints. Topline data from the Phase [--] trial in mild to moderate #AlzheimersDisease are anticipated in late Nov/early Dec. Learn more: $BIVI"  
[X Link](https://x.com/BioVie_Pharma/status/1717218064591171658)  2023-10-25T16:34Z [--] followers, [---] engagements


"Today we announced the pricing of our best efforts public offering with gross proceeds expected to be $21M. The Company intends to use the net proceeds from the offering primarily for working capital and general corporate purposes. Learn more: $BIVI"  
[X Link](https://x.com/BioVie_Pharma/status/1764742931762557184)  2024-03-04T20:01Z [---] followers, [---] engagements


"Today we announced the formation of a powerhouse Corporate Advisory Board featuring leaders from Neuralink Apple Mastercard and Cedars-Sinai to advance BioVies mission and growth. Details: $BIVI #Neuroinflammation #Biotech https://investors.bioviepharma.com/news/news-details/2025/BioVie-Unveils-Corporate-Advisory-Board-Featuring-Neuralink-Co-Founder-Former-Executives-from-Mastercard-and-Apple-and-High-Impact-Industry-Leaders-to-Advance-BioVie-Mission-and-Growth/default.aspx"  
[X Link](https://x.com/BioVie_Pharma/status/1919408170759311828)  2025-05-05T15:05Z [---] followers, [---] engagements


"Last week we held a virtual KOL event with two leading experts in the field to discuss the unmet need in #ParkinsonsDisease along with an overview of our currently enrolling SUNRISE-PD trial in newly diagnosed patients. Catch the replay here: $BIVI https://lifescievents.com/event/biovie-4/ https://lifescievents.com/event/biovie-4/"  
[X Link](https://x.com/BioVie_Pharma/status/1930274974478008783)  2025-06-04T14:46Z [---] followers, [---] engagements


"We will be presenting a poster at #ATMRD highlighting the decentralized design of our Phase [--] SUNRISE-PD clinical trial evaluating bezisterim (NE3107) in early Parkinsons disease. Learn more: #ParkinsonsDisease #MovementDisorders $BIVI https://investors.bioviepharma.com/news/news-details/2025/BioVie-to-Present-Overview-of-Phase-2-SUNRISE-PD-Trial-at-the-Advanced-Therapeutics-in-Movement--Related-Disorders-Congress/default.aspx"  
[X Link](https://x.com/BioVie_Pharma/status/1937603595668472292)  2025-06-24T20:07Z [---] followers, [---] engagements


"Our hybrid decentralized trial of bezisterim (NE3107) in early Parkinsons Disease prioritizes patient access and participation. Learn more: #ATMRD #ParkinsonsDisease #MovementDisorders $BIVI https://investors.bioviepharma.com/news/news-details/2025/BioVie-Highlights-Patient-Centric-Design-of-SUNRISE-PD-Trial-at-Advanced-Therapeutics-in-Movement--Related-Disorders-Congress-ATMRD/default.aspx https://investors.bioviepharma.com/news/news-details/2025/BioVie-Highlights-Patient-Centric-Design-of-SUNRISE-PD-Trial-at-Advanced-Therapeutics-in-Movement--Related-Disorders-Congress-ATMRD/default.aspx"  
[X Link](https://x.com/BioVie_Pharma/status/1938209746345140627)  2025-06-26T12:16Z [---] followers, [---] engagements


"Dr. Mark Stacy highlighted the potential of bezisterim as a treatment targeting #neuroinflammation in Parkinson's disease & its innovative P2 trial design on @PracticalNeuros podcast. Listen here: #ParkinsonsAwareness #BrainHealthMonth $BIVI https://practicalneurology.com/diseases-diagnoses/movement-disorders/the-evolving-therapeutic-landscape-for-parkinson-disease/36164/ https://practicalneurology.com/diseases-diagnoses/movement-disorders/the-evolving-therapeutic-landscape-for-parkinson-disease/36164/"  
[X Link](https://x.com/BioVie_Pharma/status/1939686243714916386)  2025-06-30T14:03Z [---] followers, [---] engagements


"In a keynote session today at #ARC2025 we presented data highlighting bezisterims potential to target epigenetic-driven age acceleration as a treatment for #Alzheimers and other #neurodegenerative diseases of aging. Learn more here: #Neuroscience $BIVI https://investors.bioviepharma.com/news/news-details/2025/BioVie-Announces-Data-Highlighting-Bezisterims-Potential-to-Slow-or-Reverse-Biological-Aging-and-Neurodegeneration-Featured-as-a-Keynote-Talk-at-the-7th-World-Aging-and-Rejuvenation-Conference/default.aspx"  
[X Link](https://x.com/BioVie_Pharma/status/1942917442587488562)  2025-07-09T12:03Z [---] followers, [---] engagements


"Were thrilled to announce the appointment of Amy S. Chappell MD FAAN and Kameel D. Farag to our Board of Directors. Details: #Biotech #Neuroinflammation #Neurology $BIVI https://investors.bioviepharma.com/news/news-details/2025/BioVie-Appoints-Industry-Veterans-Amy-Chappell-MD-FAAN-and-Kameel-Farag-to-Board-of-Directors/default.aspx https://investors.bioviepharma.com/news/news-details/2025/BioVie-Appoints-Industry-Veterans-Amy-Chappell-MD-FAAN-and-Kameel-Farag-to-Board-of-Directors/default.aspx"  
[X Link](https://x.com/BioVie_Pharma/status/1947636692883567074)  2025-07-22T12:35Z [---] followers, [---] engagements


"We presented data that suggest bezisterims potential to target epigenetic-driven age deceleration as a treatment for #Alzheimers disease and other #neurodegenerative diseases of aging. Learn more: #Aging #Longevitiy #Neuroscience $BIVI https://investors.bioviepharma.com/news/news-details/2025/BioVie-Presented-Data-Highlighting-that-Patients-Treated-with-Bezisterim-Potentially-Experienced-an-Age-Deceleration-Advantage-Compared-to-Placebo-on-10-Different-Biological-Clocks-at-the-2nd-World-Conference-on-Aging-and-Gerontology/default.aspx"  
[X Link](https://x.com/BioVie_Pharma/status/1948441277155901641)  2025-07-24T17:52Z [---] followers, [---] engagements


"BioVie was a poster winner at this years #ATMRD2025. Our CMO and lead author spoke with @neurology_live about the presentation. Watch here: #ParkinsonsDisease #ClinicalTrials #Neuroinflammation $BIVI https://www.neurologylive.com/view/designing-hybrid-trial-bezisterim-early-stage-pd-mark-stacy-joseph-palumbo https://www.neurologylive.com/view/designing-hybrid-trial-bezisterim-early-stage-pd-mark-stacy-joseph-palumbo"  
[X Link](https://x.com/BioVie_Pharma/status/1950905682326089914)  2025-07-31T13:05Z [---] followers, [---] engagements


"We presented the ADDRESS-LC P2 trial design of our ongoing study exploring bezisterim to treat #neurological symptoms at the #LongCOVID @KeystoneSymp. Learn more: #BrainFog #Fatigue #Neuroinflammation #KSLongCOVID26 $BIVI https://investors.bioviepharma.com/news/news-details/2025/BioVie-Highlighted-ADDRESS-LC-Phase-2-Trial-Design-Exploring-Bezisterim-for-the-Treatment-of-Neurological-Symptoms-of-Long-COVID-at-Keystone-Symposia-on-Long-COVID-and-Other-Post-Acute-Infection-Syndromes/default.aspx"  
[X Link](https://x.com/BioVie_Pharma/status/1955725523881001144)  2025-08-13T20:17Z [---] followers, [---] engagements


"Were at #LongCOVIDIntl [----] presenting our ongoing P2 ADDRESS-LC trial evaluating the efficacy safety & tolerability of bezisterim in participants with #LongCOVID enriched for #BrainFog & #fatigue. @Academic_MedEdu Learn about the trial here: $BIVI http://www.addresslongcovid.com http://www.addresslongcovid.com"  
[X Link](https://x.com/BioVie_Pharma/status/1991265193658061287)  2025-11-19T21:59Z [---] followers, [---] engagements


"BioVie is proud to announce that our CFO Wendy Kim was selected as a winner of the Third Annual Women CFOs of the Year Awards by the @feisv chapter honoring outstanding finance leaders for their achievements. #LifeSciences #BiotechLeadership $BIVI http://bit.ly/4rBiQP3 http://bit.ly/4rBiQP3"  
[X Link](https://x.com/anyuser/status/1996582455990514131)  2025-12-04T14:08Z [---] followers, [---] engagements


"Our CEO Cuong Do joined @proactive_x to provide an update on the companys lead candidate bezisterim currently in clinical trials for patients with #Parkinsonss & #longCOVID. Learn about clinical & regulatory catalysts in [----] $BIVI https://www.youtube.com/watchv=_RI6hZkiSvI&t=23s https://www.youtube.com/watchv=_RI6hZkiSvI&t=23s"  
[X Link](https://x.com/anyuser/status/2001669861697540333)  2025-12-18T15:04Z [---] followers, [---] engagements


"Our CEO Cuong Do spoke with @cpiller about patterns of alleged misconduct at certain South Florida clinical trial sites and the devastating implications for the Alzheimers community- from patients & families to researchers & drug developers seeking to make a difference. My latest story: Alzheimers drug developers accuse clinical trial sites of faking data Science AAAS https://t.co/C0wsVrZWct My latest story: Alzheimers drug developers accuse clinical trial sites of faking data Science AAAS https://t.co/C0wsVrZWct"  
[X Link](https://x.com/anyuser/status/2009666647666438242)  2026-01-09T16:40Z [---] followers, [---] engagements


"Together these organizations have given voice to millions suffering in silence. Our team and #LongCOVID patients researchers & doctors are grateful for your active participation + determination to advance research toward a treatment. #Advocacy #PatientCentricResearch"  
[X Link](https://x.com/anyuser/status/2018708956026200419)  2026-02-03T15:31Z [---] followers, [--] engagements


"📍There are [--] sites actively recruiting across the U.S. To learn more about participating in the ADDRESS-LC trial visit $BIVI https://addresslongcovid.com https://addresslongcovid.com"  
[X Link](https://x.com/anyuser/status/2018708957385146544)  2026-02-03T15:31Z [---] followers, [--] engagements


"#ICYMI: Our CEO held a virtual investor webinar to discuss bezisterim BioVies lead candidate targeting #inflammation and insulin resistance key drivers of #Alzheimers #Parkinsons & #LongCOVID where it has shown encouraging signals across clinical studies"  
[X Link](https://x.com/anyuser/status/2003183216203583988)  2025-12-22T19:17Z [---] followers, [---] engagements


"Catch the replay here: $BIVI https://www.redchip.com/webinar/BIVI/87918761553 https://www.redchip.com/webinar/BIVI/87918761553"  
[X Link](https://x.com/BioVie_Pharma/status/2003183218217091309)  2025-12-22T19:17Z [---] followers, [---] engagements


"Enrollment is complete in our Phase [--] SUNRISE-PD clinical trial evaluating bezisterim for the treatment of motor & non-motor symptoms in patients with early-stage #Parkinsons disease. Topline results expected in 1H [----]. Learn more: #Neurology $BIVI https://investors.bioviepharma.com/news/news-details/2026/BioVie-Completes-Enrollment-in-Phase-2-SUNRISE-PD-Trial-in-Early-Parkinsons-Disease/default.aspx https://investors.bioviepharma.com/news/news-details/2026/BioVie-Completes-Enrollment-in-Phase-2-SUNRISE-PD-Trial-in-Early-Parkinsons-Disease/default.aspx"  
[X Link](https://x.com/anyuser/status/2009255071901499463)  2026-01-08T13:25Z [---] followers, [---] engagements


"BioVie announced the acceptance of two abstracts from studies on our lead candidate bezisterim in the treatment of #Alzheimers & #LongCOVID at the upcoming [----] American College of Psychiatrists (ACP) annual meeting. Read: $BIVI https://investors.bioviepharma.com/news/news-details/2026/BioVie-Announces-Abstracts-Accepted-for-Presentation-at-the-2026-American-College-of-Psychiatrists-Annual-Meeting/default.aspx https://investors.bioviepharma.com/news/news-details/2026/BioVie-Announces-Abstracts-Accepted-for-Presentation-at-the-2026-American-College-of-Psychiatrists-Annual-Meeting/default.aspx"  
[X Link](https://x.com/anyuser/status/2021936983208329613)  2026-02-12T13:18Z [---] followers, [--] engagements


"#Parkinsons care has focused on dopamine for decades. BioVie is testing a different angle: targeting brain inflammation + insulin resistance. Phase [--] SUNRISE-PD enrollment complete with topline data expected Apr/May [----]. Multiple [----] catalysts ahead. #Biotech $BIVI $BIVI BioVie could offer first new Parkinsons therapy in decades https://t.co/vy6Zzbti4P @BioVie_Pharma $BIVIW #BIVI #BIVIW $BIVI BioVie could offer first new Parkinsons therapy in decades https://t.co/vy6Zzbti4P @BioVie_Pharma $BIVIW #BIVI #BIVIW"  
[X Link](https://x.com/anyuser/status/2022048426498961757)  2026-02-12T20:41Z [---] followers, [---] engagements


"#Parkinsons care has focused on dopamine for decades. BioVie is testing a different angle: targeting brain inflammation + insulin resistance. Phase [--] SUNRISE-PD enrollment complete with topline data expected Apr/May [----]. Multiple [----] catalysts ahead. #Biotech $BIVI $BIVI BioVie could offer first new Parkinsons therapy in decades https://t.co/vy6Zzbti4P @BioVie_Pharma $BIVIW #BIVI #BIVIW $BIVI BioVie could offer first new Parkinsons therapy in decades https://t.co/vy6Zzbti4P @BioVie_Pharma $BIVIW #BIVI #BIVIW"  
[X Link](https://x.com/anyuser/status/2022048426498961757)  2026-02-12T20:41Z [---] followers, [---] engagements


"$BIVI BioVie could offer first new Parkinsons therapy in decades @BioVie_Pharma $BIVIW #BIVI #BIVIW https://tinyurl.com/242nwo86 https://tinyurl.com/242nwo86"  
[X Link](https://x.com/anyuser/status/2021610688758559066)  2026-02-11T15:42Z 32K followers, [---] engagements


"BioVie announced the acceptance of two abstracts from studies on our lead candidate bezisterim in the treatment of #Alzheimers & #LongCOVID at the upcoming [----] American College of Psychiatrists (ACP) annual meeting. Read: $BIVI https://investors.bioviepharma.com/news/news-details/2026/BioVie-Announces-Abstracts-Accepted-for-Presentation-at-the-2026-American-College-of-Psychiatrists-Annual-Meeting/default.aspx https://investors.bioviepharma.com/news/news-details/2026/BioVie-Announces-Abstracts-Accepted-for-Presentation-at-the-2026-American-College-of-Psychiatrists-Annual-Meeting/default.aspx"  
[X Link](https://x.com/anyuser/status/2021936983208329613)  2026-02-12T13:18Z [---] followers, [--] engagements


"BioVies current P2 ADDRESS-LC clinical trial evaluating bezisterim for the treatment of neurological symptoms associated with #LongCOVID was designed to address the unmet needs of the community and made possible with support from @PlzSolveCFS & @patientled"  
[X Link](https://x.com/anyuser/status/2018708953606058114)  2026-02-03T15:31Z [---] followers, [---] engagements


"Together these organizations have given voice to millions suffering in silence. Our team and #LongCOVID patients researchers & doctors are grateful for your active participation + determination to advance research toward a treatment. #Advocacy #PatientCentricResearch"  
[X Link](https://x.com/anyuser/status/2018708956026200419)  2026-02-03T15:31Z [---] followers, [--] engagements


"📍There are [--] sites actively recruiting across the U.S. To learn more about participating in the ADDRESS-LC trial visit $BIVI https://addresslongcovid.com https://addresslongcovid.com"  
[X Link](https://x.com/anyuser/status/2018708957385146544)  2026-02-03T15:31Z [---] followers, [--] engagements


"📊 BioVie Advances Breakthrough Treatments Targeting Aging-Related Diseases @BioVie_Pharma is tirelessly developing groundbreaking therapies that go beyond symptom management to address the root causes of aging-related diseases aiming to transform long-term patient outcomes. @vincemedia1 Watch the Newest @NewToTheStreet interview here👇🏻👇🏻👇🏻 Check them out here👇🏻👇🏻👇🏻 #bioVie #neuroscience #medical #breakthrough #innovation #businessupdate #businessnews #business #news#newtothestreet http://bioviepharma.com https://bit.ly/NTTS-BioVieTargetsAlzheimerParkinsonandLongCOVID"  
[X Link](https://x.com/anyuser/status/2015833982278238408)  2026-01-26T17:07Z 70.3K followers, [----] engagements


"Enrollment in BioVies Phase [--] SUNRISE-PD clinical trial evaluating bezisterim for the treatment of motor & non-motor symptoms in patients with early-stage #Parkinsons disease was made possible with the support of leading advocacy organizations"  
[X Link](https://x.com/anyuser/status/2016183292144283762)  2026-01-27T16:15Z [---] followers, [---] engagements


"THANK YOU @MichaelJFoxOrg @DavisPhinneyFND and @ParkinsonDotOrg Our team and the Parkinsons community at large is grateful for your fierce dedication to advancing research toward treatments for patients. #ParkinsonsDisease #Advocacy #PatientCentricResearch $BIVI"  
[X Link](https://x.com/anyuser/status/2016183294291751052)  2026-01-27T16:15Z [---] followers, [--] engagements


"Clinical Trials & Pharma Engagement: Worked with @BioVie_Pharma on study design & recruitment for their Bezisterim trial for #LongCovid an investigational drug that has shown promise in neurodegenerative conditions. /5"  
[X Link](https://x.com/anyuser/status/2003587652428398821)  2025-12-23T22:04Z 26.2K followers, [---] engagements


"Our CEO Cuong Do spoke with @cpiller about patterns of alleged misconduct at certain South Florida clinical trial sites and the devastating implications for the Alzheimers community- from patients & families to researchers & drug developers seeking to make a difference. My latest story: Alzheimers drug developers accuse clinical trial sites of faking data Science AAAS https://t.co/C0wsVrZWct My latest story: Alzheimers drug developers accuse clinical trial sites of faking data Science AAAS https://t.co/C0wsVrZWct"  
[X Link](https://x.com/anyuser/status/2009666647666438242)  2026-01-09T16:40Z [---] followers, [---] engagements


"My latest story: Alzheimers drug developers accuse clinical trial sites of faking data Science AAAS https://www.science.org/content/article/alzheimer-s-drug-developers-accuse-clinical-trial-sites-faking-data https://www.science.org/content/article/alzheimer-s-drug-developers-accuse-clinical-trial-sites-faking-data"  
[X Link](https://x.com/anyuser/status/2008951286956441641)  2026-01-07T17:18Z [----] followers, [----] engagements


"Enrollment is complete in our Phase [--] SUNRISE-PD clinical trial evaluating bezisterim for the treatment of motor & non-motor symptoms in patients with early-stage #Parkinsons disease. Topline results expected in 1H [----]. Learn more: #Neurology $BIVI https://investors.bioviepharma.com/news/news-details/2026/BioVie-Completes-Enrollment-in-Phase-2-SUNRISE-PD-Trial-in-Early-Parkinsons-Disease/default.aspx https://investors.bioviepharma.com/news/news-details/2026/BioVie-Completes-Enrollment-in-Phase-2-SUNRISE-PD-Trial-in-Early-Parkinsons-Disease/default.aspx"  
[X Link](https://x.com/anyuser/status/2009255071901499463)  2026-01-08T13:25Z [---] followers, [---] engagements


"#ICYMI: Our CEO held a virtual investor webinar to discuss bezisterim BioVies lead candidate targeting #inflammation and insulin resistance key drivers of #Alzheimers #Parkinsons & #LongCOVID where it has shown encouraging signals across clinical studies"  
[X Link](https://x.com/anyuser/status/2003183216203583988)  2025-12-22T19:17Z [---] followers, [---] engagements


"Catch the replay here: $BIVI https://www.redchip.com/webinar/BIVI/87918761553 https://www.redchip.com/webinar/BIVI/87918761553"  
[X Link](https://x.com/BioVie_Pharma/status/2003183218217091309)  2025-12-22T19:17Z [---] followers, [---] engagements


"A study published in @NatImmunol provides additional evidence that #LongCOVID is associated with chronic #inflammation & metabolic dysregulation. The findings align w/ the MoA of bezisterim which targets upstream immune signaling involved in chronic inflammation"  
[X Link](https://x.com/anyuser/status/2002123793305907680)  2025-12-19T21:08Z [---] followers, [---] engagements


"At BioVie we are actively studying bezisterim in Long COVID - for information about the currently enrolling ADDRESS-LC trial visit Read the study here: #BrainFog #Fatigue #Neuroinflammation #InsulinResistance #LongCOVID $BIVI https://www.nature.com/articles/s41590-025-02353-x https://addresslongcovid.com/ https://www.nature.com/articles/s41590-025-02353-x https://addresslongcovid.com/"  
[X Link](https://x.com/anyuser/status/2002123795562484150)  2025-12-19T21:08Z [---] followers, [--] engagements


"Our CEO Cuong Do joined @proactive_x to provide an update on the companys lead candidate bezisterim currently in clinical trials for patients with #Parkinsonss & #longCOVID. Learn about clinical & regulatory catalysts in [----] $BIVI https://www.youtube.com/watchv=_RI6hZkiSvI&t=23s https://www.youtube.com/watchv=_RI6hZkiSvI&t=23s"  
[X Link](https://x.com/anyuser/status/2001669861697540333)  2025-12-18T15:04Z [---] followers, [---] engagements


"On a recent episode of Power to the Patients our CMO Dr. Joseph Palumbo discussed why #inflammation is emerging as a critical factor in treating #neurodegenerative diseases like #Alzheimer's & #Parkinson's. Listen here: #InsulinResistance #LongCOVID https://bit.ly/4ooj0XR https://bit.ly/4ooj0XR"  
[X Link](https://x.com/anyuser/status/1999214822190383244)  2025-12-11T20:28Z [---] followers, [---] engagements


"📍A reminder to join us tomorrow for a live webinar with our CEO Cuong Do discussing bezisterims effects on #inflammation and insulin resistance two key drivers of #Alzheimers #Parkinsons and #LongCOVID. Register here: #Neuroscience $BIVI https://www.redchip.com/webinar/BIVI/87918761553 https://www.redchip.com/webinar/BIVI/87918761553"  
[X Link](https://x.com/anyuser/status/1998039143344120060)  2025-12-08T14:37Z [---] followers, [--] engagements


"On a recent episode of Power to the Patients podcast our CEO Cuong Do shares how BioVie is focused on the role of #inflammation & #insulinresistance key drivers of #Alzheimers #Parkinsons & #LongCOVID. Listen here: Watch: https://lnkd.in/gCxPufWc https://bit.ly/3Kdr6nE https://lnkd.in/gCxPufWc https://bit.ly/3Kdr6nE"  
[X Link](https://x.com/anyuser/status/1997014876083179566)  2025-12-05T18:47Z [---] followers, [---] engagements


"BioVie is proud to announce that our CFO Wendy Kim was selected as a winner of the Third Annual Women CFOs of the Year Awards by the @feisv chapter honoring outstanding finance leaders for their achievements. #LifeSciences #BiotechLeadership $BIVI http://bit.ly/4rBiQP3 http://bit.ly/4rBiQP3"  
[X Link](https://x.com/anyuser/status/1996582455990514131)  2025-12-04T14:08Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing